Monopar Therapeutics
Price & Volume
Stats
See more52W Range | $1.54-$38.50 |
Market Cap | $136.2M |
Shares Short | 21,981 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.13 |
News
See moreYahoo Finance • last year
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
Yahoo Finance • last year
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
Yahoo Finance • last year
Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference
Yahoo Finance • last year
Monopar to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
About
CEO | Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc |
CFO | Mr. Karthik Radhakrishnan CFA |
Address | 1000 Skokie Boulevard, Wilmette, IL, United States, 60091 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
